XML 97 R44.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes - Schedule of Net Deferred Income Tax Asset (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Components of Deferred Tax Assets and Liabilities [Abstract]    
Net operating loss carryforwards $ 4,742 $ 4,096
Gene therapy patent license 852
Credits 50 19
Capitalized research and development 998 1,217
Total deferred tax assets 6,642 5,332
Valuation allowance (6,392) (4,865)
Net deferred tax assets 250 467
Deferred tax liabilities    
Accruals and other (250) (467)
Net deferred tax liabilities (250) (467)
Net deferred tax assets (liabilities)